News about "Central Drugs Standard Control Organisation (CDSCO"

MSN Laboratories Launches SEMABEST, India's First Semaglutide After Patent Expiry

MSN Laboratories launches SEMABEST, India’s first semaglutide post patent expiry, priced 50 percent lower than the innovator drug and available as a pre-filled pen for improved patient access.

Central Drugs Standard Control Organisation (CDSCO | 15/04/2026 | By News Bureau |  130

Sanofi Reports Theft of Lantus Insulin Batch in India, Regulator Issues Alert

Sanofi has reported to the Central Drugs Standard Control Organisation (CDSCO) that a batch of its long-acting insulin Lantus 100 IU/mL, Batch No. 5F03478B, was stolen while being transported from Jagmohanpur on Keonjhar Road in Odisha to the company’s carrying and forwarding agent in Kolkata.

Central Drugs Standard Control Organisation (CDSCO | 04/03/2026 | By Darshana

CDSCO Launches Nationwide Inspections of Drug Manufacturing Units After Cough Syrup Deaths

The Central Drugs Standard Control Organisation (CDSCO) has initiated risk-based inspections of drug manufacturing units in six Indian states following reports of child fatalities linked to contaminated cough syrups.

Central Drugs Standard Control Organisation (CDSCO | 06/10/2025 | By Darshana |  410

New GST Rates: DCGI Orders Medical Device Makers to Update MRP Within 3 Months

The Central Drugs Standard Control Organization (CDSCO) has directed manufacturers and importers of Class C and D medical devices to update their inventories with revised MRP reflecting the newly reduced 5 percent Goods and Services Tax (GST).

Central Drugs Standard Control Organisation (CDSCO | 12/09/2025 | By Dineshwori |  701

Mankind Pharma Gets CDSCO Nod to Begin Phase 1 Trials of Novel Autoimmune Drug Candidate MKP11093

Mankind Pharma Ltd., India’s 4th largest pharmaceutical company, today announced that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical trial of MKP11093, a novel, orally administered Janus kinase-1 (JAK-1) inhibitor.

Central Drugs Standard Control Organisation (CDSCO | 08/09/2025 | By Darshana |  174

India's drug regulator to ease oversight and deploy AI for greater efficiency

India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is preparing to introduce fixed timelines for drug approvals and increase the use of artificial intelligence to strengthen efficiency and transparency.

Central Drugs Standard Control Organisation (CDSCO | 05/09/2025 | By Darshana |  480

CDSCO Flags 143 Drug Samples as Substandard in July, Eight Found Spurious

In its routine quality surveillance for July, the Central Drugs Standard Control Organisation (CDSCO) reported that 143 drug samples failed to meet quality standards, while eight were identified as spurious.

Central Drugs Standard Control Organisation (CDSCO | 29/08/2025 | By Darshana |  204

CDSCO Cancels Import Registration of Mediderma Products Over Excess Salicylic Acid

The Central Drugs Standard Control Organisation (CDSCO) has cancelled the import registration of certain skincare products from US-based Mediderma after finding salicylic acid levels far above the permissible limit.

Central Drugs Standard Control Organisation (CDSCO | 26/08/2025 | By Dineshwori |  466

ICMR, CDSCO Invite Public Comments on Draft Evaluation Protocols for In-Vitro Diagnostics

The Indian Council of Medical Research (ICMR), in collaboration with the Central Drugs Standard Control Organisation (CDSCO), has released draft standard evaluation protocols for the performance evaluation of In-Vitro Diagnostics (IVDs) for use by IVD manufacturers and testing labs in India.

Central Drugs Standard Control Organisation (CDSCO | 12/08/2025 | By Dineshwori |  260

Paracetamol Not Banned in India, Clarifies Union Minister Anupriya Patel

Union Minister of State for Chemicals and Fertilizers Anupriya Patel has clarified on social media rumours regarding a ban on paracetamol and other common medicines.

Central Drugs Standard Control Organisation (CDSCO | 06/08/2025 | By Dineshwori |  498